Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis
Conditions
- Metastatic (Stage IV) Non-squamous Non-small Cell Lung Cancer (Nsq-NSCLC) With Driver Gene Negativity
- Untreated With Systemic Therapy
Interventions
- DRUG: Nano-crystalline Megestrol Acetate Oral Suspension
- OTHER: Standard Therapy
Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Collaborators